Tanya Lewis

Vice President, Regulatory, VION PHARMACEUTICALS INC.

Companies

DiaMedica Therapeutics Inc.Board member Mar 6, 2023 to now¹
Replimune Group, Inc.Chief Dev. Oper. Off. May 11, 2021 to Jun 15, 2023²
Replimune Group, Inc.Board member Nov 3, 2020 to Apr 5, 2021³
Karyopharm Therapeutics Inc.EVP,Chief Reg.&Quality Officer Nov 5, 2019 to Mar 1, 2021⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Replimune Group, Inc. REPL135,293 shares⁵$1.5M at $10.99Jun 13, 2023
DiaMedica Therapeutics Inc. DMAC0 shares⁶Jun 3, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 13, 2023Sold 817 shares at $23.45 of Replimune Group, Inc.⁵
Jun 13, 2023Sold 12,043 shares at $24.10 of Replimune Group, Inc.⁵
May 16, 2023Sold 12,207 shares at $18.05 of Replimune Group, Inc.⁷
Apr 1, 2023Granted 40,000 shares of Replimune Group, Inc.⁸
May 16, 2022Sold 5,473 shares at $14.59 of Replimune Group, Inc.⁹
Apr 1, 2022Granted 52,500 shares of Replimune Group, Inc.¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDiaMedica Therapeutics Inc., Board member
2
SEC EDGARReplimune Group, Inc., Chief Dev. Oper. Off.
3
SEC EDGARReplimune Group, Inc., Board member
4
SEC EDGARKaryopharm Therapeutics Inc., EVP,Chief Reg.&Quality Officer
5
SEC EDGARReplimune Group, Inc. shares after the filing of Jun 13, 2023
6
SEC EDGARDiaMedica Therapeutics Inc. shares after the filing of Jun 3, 2025
7
SEC EDGARForm 4 filed May 18, 2023
8
SEC EDGARForm 4 filed Apr 4, 2023
9
SEC EDGARForm 4 filed May 18, 2022
10
SEC EDGARForm 4 filed Apr 5, 2022